Economic impact of next generation sequencing vs sequential single-gene testing modalities to detect genomic alterations in metastatic non-small cell lung cancer using a decision analytic model.-Reference-Cited by-同舟云学术

Economic impact of next generation sequencing vs sequential single-gene testing modalities to detect genomic alterations in metastatic non-small cell lung cancer using a decision analytic model.

Published:2018-05-20 Issue:15_suppl Volume:36 Page:9031-9031
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Pennell Nathan A.¹,Mutebi Alex²,Zhou Zheng-Yi³,Ricculli Marie Louise³,Tang Wenxi³,Wang Helen³,Guerin Annie⁴,Arnhart Tom²,Culver Kenneth W.²,Otterson Gregory Alan⁵

Affiliation:

1. Cleveland Clinic, Cleveland, OH;

2. Novartis Pharmaceuticals Corporation, East Hanover, NJ;

3. Analysis Group, New York, NY;

4. Analysis Group, Inc., Montreal, QC, Canada;

5. Ohio State University, Columbus, OH;

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2018.36.15_suppl.9031

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Targeted Treatments for NSCLC (Excluding EGFR/ALK/ROS-1/K-Ras);Encyclopedia of Respiratory Medicine;2022

2. Tumor Biomarker Testing for Metastatic Colorectal Cancer: a Canadian Consensus Practice Guideline;Therapeutic Advances in Medical Oncology;2022-01

3. Molecular charcterization of lung adenocarcinoma combining whole exome sequencing, copy number analysis and gene expression profiling;Expert Review of Molecular Diagnostics;2021-12-22

4. Testing for EGFR Mutations and ALK Rearrangements in Advanced Non-Small-Cell Lung Cancer: Considerations for Countries in Emerging Markets;OncoTargets and Therapy;2021-09

5. The Impact of Foundation Medicine Testing on Cancer Patients: A Single Academic Centre Experience;Frontiers in Oncology;2021-07-26